Erratum: Memantine (Ebixa) for dementia in moderately severe Alzheimer's disease

Published in NPS RADAR

Date published: About this date

Clinical content may change after this date. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment.

Information on the dose titration of memantine contained in Table 1 of the August 2008 NPS RADAR review of memantine was incorrect. The dose for the tablet formulation was correct but the dose for the oral solution was mistakenly halved.

The error has been rectified on the NPS website and all electronic copies of the review now show the correct dose (Table 1). We apologise for any confusion.

Table 1.
Initial dose titration

Week
Dose
Week 1
Morning: half a tablet or 10 drops of solution
Week 2
Morning: half a tablet or 10 drops of solution
Evening: half a tablet or 10 drops of solution
Week 3
Morning: 1 tablet or 20 drops of solution
Evening: half a tablet or 10 drops of solution
Week 4
Morning: 1 tablet or 20 drops of solution
Evening: 1 tablet or 20 drops of solution